当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Smriti Ojha
Multiple Sclerosis (MS) is a multifactorial disease with several physiologic and pathogenic mechanisms and pathways. In MS the immune system attacks the myelin sheath that provides insulation to the nerve cells in their brain, spinal cord and optic nerve. With the damaged and compromised nerve membrane, the nerve cells are not able to conduct electrical signals properly, resulting in limb numbness, paralysis, blindness and other neurological disorders [1-15]. The main purpose of this paper is to highlight advancements in nanotechnology that has enabled the clinician to cross blood brain barrier and to target the brain and CNS of the patient with multiple sclerosis. We have focused on application of nanotechnology having therapeutic and imaging components to improve tissue imaging, targeted interactions at molecular level, nerve protection and regeneration therapy. We have also discussed the pathophysiology of the disease and nanotechnology based new strategies to deliver the therapeutic candidates for the diagnosis and treatment of MS. Future advances in the development of new practical treatment modalities for the treatment of MS is currently a potential area of research.